Viking Therapeutics (NASDAQ:VKTX) is set to give its latest quarterly earnings report on Wednesday, 2025-10-22. Here's what investors need to know before the announcement.
Analysts estimate that Viking Therapeutics will report an earnings per share (EPS) of $-0.68.
Investors in Viking Therapeutics are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
Performance in Previous Earnings
In the previous earnings release, the company missed EPS by $0.14, leading to a 0.3% increase in the share price the following trading session.
Here's a look at Viking Therapeutics's past performance and the resulting price change:
| Quarter | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.44 | -0.31 | -0.27 | -0.25 |
| EPS Actual | -0.58 | -0.41 | -0.32 | -0.22 |
| Price Change % | 0.00 | -1.00 | -6.00 | 21.00 |
Market Performance of Viking Therapeutics's Stock
Shares of Viking Therapeutics were trading at $33.75 as of October 20. Over the last 52-week period, shares are down 45.44%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release.
To track all earnings releases for Viking Therapeutics visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
